Ryukyu Bank Launches M&A

News Highlights

Ryukyu Bank is making a full-scale entry into supporting medical practice succession utilizing M&A. The bank aims to promote third-party succession, as an alternative to closure or business dissolution, for medical institutions in Okinawa Prefecture struggling with a lack of successors. It recommends that chairpersons and directors begin preparations 5 to 10 years in advance, around the age of 60, and is considering collaboration with advisors specializing in the medical industry.

M&A Medical Editorial Department’s Perspective

The move by a regional financial institution to prominently feature M&A in its medical practice succession support is insightful, especially considering the specific characteristics of Okinawa Prefecture. While the lack of successors is a nationwide issue, Ryukyu Bank’s concrete proposal of M&A as an “alternative to closure or business dissolution” is significant from the perspective of maintaining and continuing regional healthcare. In particular, recommending a specific preparation period of 5 to 10 years starting around age 60 is expected to make経営者 (keieisha – business owners/managers) aware of the timeline for succession preparation, which has often been vaguely understood, and encourage action. Furthermore, collaboration with specialized medical M&A advisors will likely enable the smooth execution of schemes tailored to the business characteristics of medical institutions, which can be difficult for financial institutions to achieve alone. This could become a standard model for medical practice succession support by regional financial institutions in the future.

Points Highlighted by This News

• Ryukyu Bank has presented third-party succession through M&A as a concrete option for medical institutions in Okinawa Prefecture.
• The bank actively promotes the use of M&A as a measure to avoid closure or business dissolution in response to the issue of successor absence.
• It recommends that chairpersons and directors establish a specific succession preparation period of 5 to 10 years, starting around the age of 60.
• The support includes suggesting the engagement of specialized advisors focused on the medical industry.

Practical Questions Arising from This News

• What is the specific M&A support scheme offered by Ryukyu Bank, and what scale and medical specialties of institutions are targeted?
• How will successor companies or medical institutions be matched? Will Ryukyu Bank take the lead, or will it be decided in collaboration with specialized advisors?
• What is the envisioned process for selecting specialized advisors, and how will their fees be covered?

If You Feel “Should I Consult Too?”

If your institution’s chairperson or director is approaching 60 and feels a vague anxiety about the lack of a successor, Ryukyu Bank’s initiative presents an opportunity to show that “there are paths other than closure or business dissolution.” Considering early third-party succession can be a realistic option to continue your institution’s philosophy and contribution to regional healthcare. Begin by consulting with experts well-versed in medical M&A to explore the possibilities for a concrete succession plan tailored to your institution’s current situation and future vision.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a Small and Medium Enterprise Agency-certified M&A support institution, with a full success fee basis. Consultations are handled with strict confidentiality. Free consultation here